|

FT536 Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Masonic Cancer Center, University of Minnesota1

Indications

  • Progressive Disease1
  • Astrocytoma1
  • Glioblastoma1
  • Cancer1

Minneapolis, Minnesota1 trial

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Elizabeth C. Neil, MD

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.